Max Reinhardt - Jun 6, 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
President, Rest of World
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jun 6, 2023
Transactions value $
-$82,710
Form type
4
Date filed
6/7/2023, 09:28 PM
Previous filing
Oct 11, 2022
Next filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$41.1K -1.05K -3.36% $38.99 30.3K Jun 6, 2023 Direct F1
transaction PCRX Common Stock Sale -$41.6K -1.1K -3.62% $37.87 29.2K Jun 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.